Cannpal Animal Therapeutics Limited announced earnings results for the year ended June 30, 2018. For the period, the company reported total income of AUD 205,912 compared to AUD 6,392 a year ago. Loss before income tax was AUD 1,694,369 compared to AUD 1,688,197 a year ago. Net loss for the year attributable to members of company was AUD 1,694,369 compared to AUD 1,688,197 a year ago. Net cash outflows from operating activities were AUD 1,279,949 compared to AUD 755,924 a year ago. Basic and diluted loss per share attributable to the ordinary equity were 2.02 cents compared to 7.11 cents a year ago.